CytoDyn Inc. (CYDY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct11

CytoDyn Inc. released FY2026 Q1 earnings on October 10 EST, actual revenue USD 0, actual EPS USD -0.0044

03:00

Jul26

CytoDyn Inc. released FY2025 Annual Earnings on July 25 (EST), actual revenue USD 0, actual EPS USD 0.0018

03:00

CytoDyn Inc. released FY2025 Q4 earnings on July 25 (EST) with actual revenue of USD 0 and EPS of USD -0.0077

03:00

Jul1

CytoDyn Announces Positive Phase 2 Trial Results for Leronlimab in mCRC

12:30

Jun24

CytoDyn Initiates Leronlimab Phase II Clinical Trial for Metastatic Colorectal Cancer

12:30

May16

CytoDyn Switches to CBIZ as New Auditor

21:16

Schedules & Filings

Schedules

Filings

Oct10

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -5.913 M, EPS -0.0047

Jul25

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -6.333 M, EPS -0.0077

Apr14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.123 M, EPS -0.0041

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More